MedTrace Logo

Assess the Effect of Erythromycin on the Rate of Success in Placement of a Self-propelled Feeding Tube

NCT00999232 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2010-01-22

No results posted yet for this study

Summary

The purpose of this study is to assess the effect of erythromycin on the Rate of Success in Placement of a Self-propelled Feeding Tube.

Conditions

Interventions

DRUG

Erythromycin

Subjects receive 4x250mg erythromycin i.v. daily after intubation of a self-propelled feeding tube

DRUG

Placebo

Subjects receive 4x placebo i.v. daily after intubation of a self-propelled feeding tube

Sponsors & Collaborators

  • Canisius-Wilhelmina Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-10-31
Primary Completion
2007-07-31

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00999232 on ClinicalTrials.gov